Executive Medical Director- Translational Medicine Group Leader Aging

GSK•Waltham, MA

20h•Hybrid

About The Position

The Executive Medical Director- Translational Medicine Group Leader (TMGL) Aging will lead efforts to bridge preclinical research and clinical development, ensuring the successful transition of innovative therapeutics from the laboratory to Proof of Mechanism/Clinical Activity in the clinic. The TMGL will provide scientific leadership, strategic direction, and operational oversight for the disease area initiatives to understand mechanism of disease and clinical development strategy. This role demands expertise in disease pathobiology, translational medicine, early clinical drug development, and biomarker strategies, with a focus on driving innovation across the therapeutic area.

Requirements

Academic physician with clinical medical specialty registration, board certification/qualified
Industry experience in clinical drug development
Experience with planning clinical development for an asset and/or indication.
Pharmaceutical industry clinical research experience in Aging focused on aging biology; geroscience or age-related diseases; and potential therapeutic areas.
Direct line management and leadership experience leadership skills
Experience with planning clinical development for an asset and/or indication.

Nice To Haves

Specialist physician with PhD
Proven record of creative problem solving in clinical trials and projects (e.g., deriving causal confidence from novel sources, or qualifying a novel endpoint).
Experience working collaboratively with multiple stakeholders on complex projects.
Knowledge of translational medicine, clinical research methodology and principles of biostatistics to facilitate innovative and efficient designs of clinical trials and clinical development plans with clear data-driven decision rules
Track record of building and maintaining strong relationships with internal and external stakeholders
Strong personal network across relevant scientific and clinical thought leaders, institutions and consortia in relevant therapy area.
Future-looking and experimental track record, with demonstrable experience of tech-enable solutions in biology, translation or clinical development

Responsibilities

Provide disease-level leadership, to develop causal maps of relevant pathobiology (through identifying, accessing or generating translational datasets), and the tools/instruments (endpoints, biomarkers) that enable timely experimentation and prosecution to derisk mechanisms and programmes.
Provide translational and clinical leadership in defining and executing innovative early development strategies.
Ensure alignment of scientific and clinical strategies with business objectives through matrix leadership of large cross-functional teams.
Drive the evaluation of therapeutic potential and clinical tractability of targets within the disease area.
Identify transformational opportunities where projects can offer significant benefits to patients.
Ensure quality, on-time, and on-budget delivery of studies and programs within a therapeutic area of EPU
Design and implement experimental medicine studies to
Oversee risk assessment across programs and ensure implementation of mitigation strategies.
Manage, mentor and coach early Clinical Development Leads to foster a culture of empowerment, innovation and excellence.
Collaborate with cross-functional teams with program counterparts in Advance Pipeline Unit, Commercial, Research Tech and Development organisations.
Build and maintain networks across internal and external stakeholders, including academic institutions, CROs, and regulators.
Represent GSK effectively in external collaborations and negotiations.
Anticipate challenges and proactively develop strategies to mitigate risks.
Make decisions balancing risk/benefit with clear understanding of project impact.
Lead the writing and review of study-related documents and regulatory submissions.
Communicate confidently and effectively at all levels, internally and externally.
Champion implementation of innovative business processes and strategies to improve clinical development outcomes.